TellBio
Andover, US · Founded 2019 · Delaware corporation
TellBio is a biotechnology company founded by leading cancer researchers and clinicians from Harvard Medical School and Massachusetts General Hospital. The company focuses on oncology research and development, leveraging circulating tumor cell (CTC) technology and biomedical engineering.
Founders & leadership
TellBio was founded in 2019 by Daniel Haber, Mehmet Toner, David Ting, Shyamala Maheswaran, and Ravi Kapur.
DH
Daniel HaberFounder
MT
Mehmet TonerFounder
DT
David TingFounder
SM
Shyamala MaheswaranFounder
RK
Ravi KapurFounder
PG
PRITESH GANDHIExecutive
Board
GC
GARY CROCKERBoard director
RP
Richard PetersFounder & Executive Chairman
BP
BERNARD PETERSBoard director
Reported raises · per SEC filings
Form D private placements$11M disclosed across 5 rounds · 2019–2024
▶$1MraisedMar 2026 · 6 investors · BiotechnologyRule 506(b)
▶$1MraisedMar 2026 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- GARY CROCKERDirector
- RICHARD PETERSExecutive Officer, Director
- BERNARD PETERSDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedJul 2024 · 11 investors · BiotechnologyRule 506(b)
▶$1.2MraisedJul 2024 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- RICHARD PETERSDirector
- BERNARD PETERSDirector
- PRITESH GANDHIExecutive Officer, Director
- GARY CROCKERDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2.3MraisedMar 2023 · 23 investors · BiotechnologyRule 506(b)
▶$2.3MraisedMar 2023 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard PetersDirector
- Pritesh GandhiExecutive Officer, Director
- Gary CrockerDirector
- Bernard PetersDirector
- Offering amount
- $2.5M
- Amount sold
- $2.3M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$5MraisedMar 2021 · 29 investors · BiotechnologyRule 506(b)
▶$5MraisedMar 2021 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard PetersExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.5MraisedOct 2019 · 19 investors · BiotechnologyRule 506(b)
▶$1.5MraisedOct 2019 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard PetersExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapMission BioCapital Platinum Program Holdings LLC22 shared keywordsMission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics. The firm provides capital, operational support, and lab infrastructure through its MBC BioLabs co-working spaces to help scientific entrepreneurs launch and scale biotech startups.
GentiBio20 shared keywordsGentiBio develops engineered regulatory T-cell (EngTreg) therapies designed to reset the immune system and treat autoimmune and acute inflammatory diseases. The company builds autologous and allogeneic Treg platforms as an alternative to systemic immune-suppressive therapies.
Companies competing with TellBio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does TellBio do?
- TellBio is a biotechnology company founded by leading cancer researchers and clinicians from Harvard Medical School and Massachusetts General Hospital. The company focuses on oncology research and development, leveraging circulating tumor cell (CTC) technology and biomedical engineering.
- Who founded TellBio?
- TellBio was founded by Daniel Haber, Mehmet Toner, David Ting, Shyamala Maheswaran, Ravi Kapur in 2019.
- How much funding has TellBio raised?
- TellBio has disclosed $11M raised across 5 rounds.
- Where is TellBio headquartered?
- TellBio is headquartered in Andover, US.